Studies have found that the molecular typing of pyroptostic‐related genes (PRGs) in cervical cancer can predict prognosis, and the GNAZ/LAG3/IL1B/CA2/SPRR3 risk scoring model has been constructed. This evidence concerns the gene IL1B and cervical carcinoma.